Grifols reported EUR197.61M in Interest Expense on Debt for its fiscal quarter ending in September of 2024.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
GlaxoSmithKline 184M 22M Jun/2025
Grifols EUR 197.61M 13.11M Sep/2024
Life Technologies 0 0 Sep/2024